Literature DB >> 21980626

A decision support system for assisting fine needle aspiration diagnosis of thyroid malignancy.

Emmanouil A Zoulias1, Pantelis A Asvestas, George K Matsopoulos, Sofia Tseleni-Balafouta.   

Abstract

OBJECTIVE: To assist diagnosis of thyroid malignancy, implementing a decision support system (DSS) using fine needle aspiration biopsy (FNAB) data. STUDY
DESIGN: The set of 2,035 thyroid smears contained 1,886 smears of nonmalignancy (class 1) and 150 smears of malignancy (class 2) verified histologically. For each smear, 67 medical features were considered by the expert, forming 2,036 feature vectors, which were fed into a DSS for discriminating between malignant and nonmalignant smears. The DSS comprised a feature selection and classification module using a combination of three classifiers, the artificial neural network, the support vector machines, and the k-nearest neighbor, under the majority vote procedure.
RESULTS: The overall classification accuracy of the DSS was 98.6%, marginally better than the FNAB (97.3%). The DSS had lower sensitivity (89.1%) and better specificity (99.4%) compared to the FNAB. Regarding the smears characterized as "suspicious" by FNAB, a significant improvement of overall accuracy was obtained by the proposed DSS system (84.6%) compared to the FNAB (50.0%).
CONCLUSION: The proposed DSS provides significant improvement compared to FNAB regarding discrimination of smears characterized by an expert as "suspicious," reducing the number of patients undergoing surgical procedures.

Entities:  

Mesh:

Year:  2011        PMID: 21980626

Source DB:  PubMed          Journal:  Anal Quant Cytol Histol        ISSN: 0884-6812            Impact factor:   0.302


  2 in total

Review 1.  Artificial Intelligence in Thyroid Fine Needle Aspiration Biopsies.

Authors:  Brie Kezlarian; Oscar Lin
Journal:  Acta Cytol       Date:  2020-12-16       Impact factor: 2.319

Review 2.  Artificial Intelligence for Personalized Medicine in Thyroid Cancer: Current Status and Future Perspectives.

Authors:  Ling-Rui Li; Bo Du; Han-Qing Liu; Chuang Chen
Journal:  Front Oncol       Date:  2021-02-09       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.